imisophia Profile Banner
imisophia Profile
imisophia

@imisophia

Followers
337
Following
143
Statuses
207

Joined April 2020
Don't wanna be here? Send us removal request.
@imisophia
imisophia
5 years
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) others. Posts on this platform only reflect the views of the authors.
Tweet media one
0
2
9
@imisophia
imisophia
2 months
Congrats to @francois_pattou and team for their research identifying two distinct subtypes of MASLD – liver-specific and cardiometabolic – each with distinct risk profiles📢 find out more in @NatureMedicine
@francois_pattou
Francois Pattou
2 months
Excited to share our latest study with @stefano_romeo76 , published in @NatureMedicine! We uncover 2 distinct subtypes of MASH: 🔹 Liver-specific: Faster liver disease progression, lower CV risk. 🔹 Cardiometabolic: Higher CV/metabolic risks, incl. T2D.
0
0
2
@imisophia
imisophia
2 months
Congrats to SOPHIA PhD fellow Lucas Schreurs 🌠 who won an award for Best New Investigator Poster Research Presentation at 2024 ISPOR in Barcelona 🏆 see it here and stay tuned for our SOPHIA Blueprint for Change report, coming soon! @Third_i_eu
Tweet media one
Tweet media two
0
1
3
@imisophia
imisophia
3 months
RT @AbdTahrani: Phentyping #obesity has always been challenging. In this very interesting paper @NatureMedicine , the @imisophia team iden…
0
11
0
@imisophia
imisophia
3 months
It's here! Our major SOPHIA findings have been published in Nature Medicine 📣🩺SOPHIA researchers have separated obesity into 5 distinct subtypes of obesity - each with differing health consequences and treatment implications Read more here:
Tweet media one
0
6
8
@imisophia
imisophia
4 months
"For me, as a clinician, that's going to change how I treat patients" 👨‍⚕️🩺 Dr. @carel_leroux from @ucddublin talks about how we're working to find the predictors of risk and response for those living with #obesity - and how this impacts patient care.
0
3
6
@imisophia
imisophia
4 months
Did you know that obesity is also prevalent among those with type 1 diabetes?📣 Our latest IMI_SOPHIA publication assesses the prevalence of overweight and #obesity in those with and without #T1D in Belgium, Kuwait and Mexico.
0
1
2
@imisophia
imisophia
6 months
What influences patient decisions when selecting an obesity treatment? by @Dardhill, David Wally, and Prof @carel_leroux
0
0
2
@imisophia
imisophia
6 months
“What would be left of me?” Patient perspectives on the risks of obesity treatment: An @imisophia qualitative study by @emmaefarrell @JNadglowskiOAC @EvaHollmann @carel_leroux and @Deemcgillicuddy
0
2
4
@imisophia
imisophia
6 months
"The right tool at the right moment" - @francois_pattou from @CHU_Lille discusses how our SOPHIA federated database gives him the power to securely combine and analyse patient data with scientists and data sources across Europe 🌍🖥️ Find out more here
0
1
4
@imisophia
imisophia
7 months
"A complex lived experience" - @Deemcgillicuddy speaks with @werdalnajim from @ucddublin about the importance of the patient experience in obesity research and how this helps us improve obesity care 💚 Find out more here
0
2
5
@imisophia
imisophia
7 months
Important work from SOPHIA partner @EASOobesity 👏
@EASOobesity
EASO
7 months
Professor @busetto_lucao responds to the new EASO publication in @NatureMedicine on a framework for diagnosing, staging, and managing obesity in adults. ➡️ The need for a clinical approach that goes beyond BMI.
Tweet media one
0
0
1
@imisophia
imisophia
7 months
🚨 New Study Alert! 🚨 “Patient perspectives on personalised medicine for obesity: An IMI2 project” highlights the importance of patient involvement in developing obesity treatments @emmaefarrell @carel_leroux @JNadglowskiOAC @Deemcgillicuddy @EvaHollmann
0
1
3
@imisophia
imisophia
7 months
Prof @carel_leroux remarked that patients are generally very optimistic about the potential for personalised obesity medicine but also raise a number of legitimate concerns that will be of interest to clinicians, industry, and policy makers @IHIEurope
0
1
4
@imisophia
imisophia
8 months
Congrats to a successful SOPHIA symposium at #ICO2024 💥 @carel_leroux, Miroslava Guadjardo, Ebaa Al Ozairi, @werdalnajim and Elena Startseva represented the entire SOPHIA consortium at our symposium in Sao Paulo, Brazil 🇧🇷🌎
Tweet media one
0
2
3
@imisophia
imisophia
8 months
LIVE from #ICO2024 🎥"We had to redefine how we think about obesity" SOPHIA coordinator @carel_leroux from @ucddublin speaks about our transformative research in the field of #obesity care at the ICO SOPHIA symposium in Sao Paulo, Brazil 🇧🇷
0
1
2
@imisophia
imisophia
8 months
Great work by SOPHIA partner @EASO on how to use first person language to address weight bias in #obesity research and healthcare 💚
@EASOobesity
EASO
8 months
Check our our First Person Language Guide: Addressing Weight Bias This guide aims to support the development of non-stigmatising research, project outputs and other communications. Thanks to @xramossalas! Download here:
Tweet media one
0
3
5
@imisophia
imisophia
8 months
Join us at the SOPHIA symposium at #ICO2024, Sao Paulo, Brazil, Wed 26, 10-11:30 in Room 4 📣as @carel_leroux (@ucddublin) Ebaa Al Ozairi (@dasmaninstitute) and @werdalnajim (@ucddublin ) present our SOPHIA research and how we're working together to improve obesity care 💚
Tweet media one
0
1
4
@imisophia
imisophia
9 months
Our new website is here! ✨ New look, same objective - a new future for #obesity care 💚 Check out the website to explore our partners, goals and our published results here:
Tweet media one
0
3
6
@imisophia
imisophia
9 months
More from out #IMISOPHIA Symposium at #ECO24 in Venice @EASOobesity @IHIEurope
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
1